United Therapeutics CorporationUTHRNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank71
3Y CAGR-2.4%
5Y CAGR+4.4%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-2.4%/yr
vs +21.3%/yr prior
5Y CAGR
+4.4%/yr
Recent deceleration
Acceleration
-23.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 16.17 | +21.2% |
| 2024 | 13.34 | +27.7% |
| 2023 | 10.45 | -39.9% |
| 2022 | 17.40 | -14.7% |
| 2021 | 20.39 | +56.5% |
| 2020 | 13.03 | +135.3% |
| 2019 | -36.92 | -559.2% |
| 2018 | 8.04 | -48.4% |
| 2017 | 15.58 | +77.0% |
| 2016 | 8.80 | - |